IVF Devices and Consumables Market by Instrument (Incubators, Cryosystem, Imaging System, Cabinet, Ovum Aspiration Pump, Sperm Separation System, Micromanipulator, Accessories and Disposables, and Others), by Reagent & Media (Cryopreservation Media, Semen Processing Media, Ovum Processing Media, and Embryo Culture Media), by Technique (Fresh Embryo Transfer Technique, Frozen Embryo Transfer Technique, and Donor Egg IVF Technique), and by End User (Fertility Clinics, Hospitals, Surgical Centers, and Clinical Research Institutes) - Global Opportunity Analysis and Industry Forecast, 2014-2023
In-vitro fertilization (IVF) is a type of assisted reproductive technology in which the ovum is artificially fertilized in laboratory settings and then implanted into the uterus. IVF is one of the popular treatments, which has assisted couples with infertility problems, single mothers, and the LGBT community to procreate. The global IVF devices and consumables market was valued at $1,506 million in 2016, and is estimated to reach at $4,972 million by 2023, registering a CAGR of 18.3% from 2017 to 2023.
The global IVF devices market is projected to witness a substantial growth in future owing to rise in incidence of infertility cases, emerging trend of delayed pregnancies among women, technological advancements in IVF procedures, and increased occurrences of gamete donations. Furthermore, rise in health awareness on fertility issues, availability of IVF treatments, increase in disposable income and favorable reimbursement policies further augment the market growth.
Recent innovations in IVF technology, such as embryoscope and capsule IVF, are anticipated to augment the demand for IVF devices in future. However, strenuous maintenance issues, high cost of devices, multiple pregnancies, and ethical considerations are anticipated to hinder the market growth. Increase in upsurge of fertility clinics and same sex marriages offer lucrative growth opportunities in future. In addition, fertility tourism provides ample growth opportunities especially in the developing economies.
The global IVF devices and consumables market is segmented into IVF instruments, reagents and media, technique, end users, and geography. The instruments market considered in this report include, sperm separation system, cryosystem, incubator, imaging system, disposables and consumables ovum aspiration pump, IVF cabinet, micromanipulator, IVF accessories and disposables, and others. In the instruments market, micromanipulator generated the highest revenue owing to its extensive use in various stages of the IVF procedure. However, sperm separation system segment witnesses a significant growth due to its extensive use in healthy sperm selection and gender determination. Based on reagents and media, the global IVF devices market is categorized into cryopreservation media, semen processing media, ovum processing media, and embryo culture media.
The IVF devices and consumables market by techniques is categorized into fresh embryo transfer technique, frozen egg transfer technique, and donor egg transfer technique. By end-users, it is categorized into fertility clinics, hospitals, surgical centers, and clinical research institutes. By geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The report provides extensive competitive analysis and profiles of key market players, such as Cook Medical, Inc., Cooper Companies, Inc., Genea Biomedx, JXTG Holdings, Inc., Merck KGAA, Ovascience, Inc., Oxford Gene Technology, Progyny, Inc. Thermo Fisher Scientific, Inc., and Vitrolife AB. The other players in the value chain include GlaxoSmithKline PLC (Viiv Healthcare Group of Companies), AbbVie Inc., Bristol-Myers Squibb Company, and AstraZeneca plc and others.
KEY BENEFITS FOR STAKEHOLDERS
This report entails a detailed quantitative analysis of the current market trends from 2014 to 2023 to identify the prevailing opportunities.
Market estimations are based on comprehensive analysis of the key developments in the industry.
In-depth analysis based on geography assists to understand the regional market and the strategic business planning.
The development strategies adopted by key manufacturers are enlisted to understand the competitive scenario of the market.
KEY MARKET SEGMENTS
By Instrument
Incubators
Cryosystem
Imaging System
Cabinet
Ovum Aspiration Pump
Sperm Separation System
Micromanipulator
Accessories and Disposables
Others
By Reagents & Media
Cryopreservation Media
Semen Processing Media
Ovum Processing Media
Embryo Culture Media
By Technique
Fresh Embryo Transfer Technique
Frozen Embryo Transfer Technique
Donor Egg IVF Technique
By End User
Fertility Clinics
Hospitals
Surgical Centers
Clinical Research Institutes
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Rest of Europe
Asia-Pacific
India
China
Japan
Australia
Rest of Asia-Pacific
LAMEA
Latin America
Brazil
Middle East
Africa
The global IVF devices market is projected to witness a substantial growth in future owing to rise in incidence of infertility cases, emerging trend of delayed pregnancies among women, technological advancements in IVF procedures, and increased occurrences of gamete donations. Furthermore, rise in health awareness on fertility issues, availability of IVF treatments, increase in disposable income and favorable reimbursement policies further augment the market growth.
Recent innovations in IVF technology, such as embryoscope and capsule IVF, are anticipated to augment the demand for IVF devices in future. However, strenuous maintenance issues, high cost of devices, multiple pregnancies, and ethical considerations are anticipated to hinder the market growth. Increase in upsurge of fertility clinics and same sex marriages offer lucrative growth opportunities in future. In addition, fertility tourism provides ample growth opportunities especially in the developing economies.
The global IVF devices and consumables market is segmented into IVF instruments, reagents and media, technique, end users, and geography. The instruments market considered in this report include, sperm separation system, cryosystem, incubator, imaging system, disposables and consumables ovum aspiration pump, IVF cabinet, micromanipulator, IVF accessories and disposables, and others. In the instruments market, micromanipulator generated the highest revenue owing to its extensive use in various stages of the IVF procedure. However, sperm separation system segment witnesses a significant growth due to its extensive use in healthy sperm selection and gender determination. Based on reagents and media, the global IVF devices market is categorized into cryopreservation media, semen processing media, ovum processing media, and embryo culture media.
The IVF devices and consumables market by techniques is categorized into fresh embryo transfer technique, frozen egg transfer technique, and donor egg transfer technique. By end-users, it is categorized into fertility clinics, hospitals, surgical centers, and clinical research institutes. By geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The report provides extensive competitive analysis and profiles of key market players, such as Cook Medical, Inc., Cooper Companies, Inc., Genea Biomedx, JXTG Holdings, Inc., Merck KGAA, Ovascience, Inc., Oxford Gene Technology, Progyny, Inc. Thermo Fisher Scientific, Inc., and Vitrolife AB. The other players in the value chain include GlaxoSmithKline PLC (Viiv Healthcare Group of Companies), AbbVie Inc., Bristol-Myers Squibb Company, and AstraZeneca plc and others.
KEY BENEFITS FOR STAKEHOLDERS
This report entails a detailed quantitative analysis of the current market trends from 2014 to 2023 to identify the prevailing opportunities.
Market estimations are based on comprehensive analysis of the key developments in the industry.
In-depth analysis based on geography assists to understand the regional market and the strategic business planning.
The development strategies adopted by key manufacturers are enlisted to understand the competitive scenario of the market.
KEY MARKET SEGMENTS
By Instrument
Incubators
Cryosystem
Imaging System
Cabinet
Ovum Aspiration Pump
Sperm Separation System
Micromanipulator
Accessories and Disposables
Others
By Reagents & Media
Cryopreservation Media
Semen Processing Media
Ovum Processing Media
Embryo Culture Media
By Technique
Fresh Embryo Transfer Technique
Frozen Embryo Transfer Technique
Donor Egg IVF Technique
By End User
Fertility Clinics
Hospitals
Surgical Centers
Clinical Research Institutes
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Rest of Europe
Asia-Pacific
India
China
Japan
Australia
Rest of Asia-Pacific
LAMEA
Latin America
Brazil
Middle East
Africa
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENT
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. ALTERNATIVE TECHNOLOGIES
3.2.1. Intrauterine insemination (IUI) technique
3.2.1.1. Factors assessed for the procedure
3.2.1.2. Benefits of this technique
3.2.1.3. Risks
3.2.2. Difference between IUI and IVF technique
3.2.3. GIFT technique
3.2.3.1. Difference between GIFT and IVF technique
3.2.4. ZIFT technique
3.2.4.1. Differences between ZIFT and IVF technique
3.3. REPLACING IVF PROCEDURES BY FERTILITY DRUGS AND SURGERIES
3.3.1. Female infertility treatments
3.3.1.1. Limitations of fertility drugs
3.3.2. Male infertility treatments
3.4. COSTS RELATED TO IVF PROCEDURES
3.5. ROLE OF DONORS IN THE IVF MARKET
3.5.1. Egg donation
3.5.2. Egg sharing
3.5.3. Sperm donation
3.5.4. Embryo donation/adoption
3.5.5. Donation for research
3.6. SURROGACY
3.6.1. Legal issues
3.7. IVF TRENDS IN SAME SEX COUPLES
3.7.1. Artificial insemination
3.7.2. Surrogate mothers
3.7.3. In-vitro fertilization
3.8. ADVANCED IVF TECHNOLOGIES
3.8.1. Capsule IVF
3.8.2. Three parent IVF
3.8.2.1. Ethical concerns
3.8.3. Mini IVF
3.8.3.1. Advantages
3.8.3.2. Drawbacks
3.8.4. Embryo Scope
3.8.4.1. Advantages
3.8.5. PICSI
3.9. FERTILITY TREATMENT AND GENDER SELECTION
3.9.1. Methods of sex selection
3.9.1.1. Gradient method
3.9.1.2. Flow cytometry technique
3.9.1.3. Pre-implantation genetic diagnosis (PGD)
3.9.1.4. Ethical and legal issues
3.10. METABOLOMICS IN EMBRYO SCREENING METHODS
3.11. APPLICATION OF STEM CELLS IN IVF
3.12. IVF AND RESOURCE POOR COUNTRIES
3.13. KEY FINDINGS
3.13.1. Top impacting factors
3.13.2. Top investment pockets
3.13.3. Top winning strategies
3.14. PORTERS FIVE FORCES ANALYSIS
3.14.1. High competition and large number reduces the power of suppliers
3.14.2. Scattered nature and large count of end users moderates the buyer power
3.14.3. High capital cost lowers the threat of new entrants
3.14.4. Industry rivalry is intense due to presence of few dominant competitors
3.14.5. Lack of efficient substitutes lowers the threat from substitutes
3.15. VALUE CHAIN ANALYSIS
3.16. PATENT ANALYSIS
3.16.1. Patent analysis by year
3.16.2. Patents analysis by country
3.17. REGULATORY ISSUES AND LEGISLATIONS
3.18. INSURANCE REIMBURSEMENT SCENARIO
3.19. CLINICAL TRIALS
3.19.1. Trial 1: To study the DHEA outcomes on poor responders of IVF
3.19.2. Trial 2: Use of Metformin in IVF treatment of polycystic ovary syndrome
3.19.3. Trial 3- Treatment of first line unexplained infertility by IVF and IUI in controlled ovarian stimulation
3.19.4. Trial 4: Fast track to IVF (FASTT) Vs conventional infertility treatment
3.19.5. Trial 5: To study the evaluation of multiple doses of NT100 in women with repeated IVF failures
3.20. DRIVERS
3.20.1. Delayed pregnancies in women
3.20.2. Rise in global infertility rates
3.20.3. Advancement in technology
3.20.4. Rise in gamete donations
3.20.5. Rise in disposable income
3.20.6. Increase in success rates
3.21. RESTRAINTS
3.21.1. Cost constraints
3.21.2. Ethical and legal issues
3.21.3. Multiple pregnancies
3.21.4. Low awareness level
3.22. OPPORTUNITIES
3.22.1. Fertility tourism
3.22.2. Growing number of fertility clinics
3.22.3. Rise in same sex marriages
CHAPTER 4 IVF DEVICES MARKET, BY INSTRUMENTS
4.1. GLOBAL IVF MARKET BY INSTRUMENTS TYPES, 2014-2023, ($MILLION)
4.1.1. Incubators
4.1.1.1. Global IVF incubators market by region
4.1.2. Cryosystem
4.1.2.1. Global IVF cryosystem market by Region
4.1.3. Imaging system
4.1.3.1. Global IVF Imaging system market by Region
4.1.4. Cabinet (work station)
4.1.4.1. Global IVF cabinets market by Region
4.1.5. Ovum aspiration pump
4.1.5.1. Global IVF ovum aspiration pump market by Region
4.1.6. Sperm separation system
4.1.6.1. Global IVF sperm separation system market by Region
4.1.7. Micro Manipulator System
4.1.7.1. Global IVF Micromanipulator market by Region
4.1.8. Others
4.1.8.1. Global IVF other instruments market by Region
4.2. ACCESSORIES AND DISPOSABLES
4.2.1. Semen analysis chamber
4.2.2. Plastic ware
4.2.3. Oocyte retrieval needles
4.2.4. Miscellaneous disposables
4.2.5. Global IVF accessories and disposables market by region
CHAPTER 5 IVF DEVICES AND CONSUMABLES MARKET BY REAGENTS AND MEDIA
5.1. GLOBAL IVF MARKET BY REAGENTS AND MEDIA TYPES, 2014-2023, ($MILLION)
5.2. CRYOPRESERVATION MEDIA
5.2.1. Embryo cryopreservation media
5.2.2. Sperm cryopreservation media
5.2.3. Oocyte cryopreservation media
5.2.4. Global IVF cryopreservation media market by region
5.3. SEMEN PROCESSING MEDIA
5.3.1. Global IVF semen processing media market by region
5.4. OVUM PROCESSING MEDIA
5.4.1. Global IVF ovum processing media market by region
5.5. EMBRYO CULTURE MEDIA
5.5.1. Global IVF embryo culture media market by region
CHAPTER 6 IVF DEVICES AND CONSUMABLES MARKET BY TECHNIQUE
6.1. GLOBAL IVF MARKET, BY TECHNIQUE, 2014-2023 ($MILLION)
6.2. FRESH EMBRYO TRANSFER TECHNIQUE
6.2.1. Drivers
6.2.1.1. Trends of delayed pregnancies
6.2.1.2. Growing rates of infertility
6.2.2. Restraints
6.2.2.1. Cost involved in the treatment
6.2.2.2. Reimbursements issues with fresh embryo ivf cycles
6.2.3. Global fresh embryo IVF cycle market, by region
6.3. FROZEN EMBRYO TRANSFER TECHNIQUE (FER)
6.3.1. Reasons to use this technique
6.3.2. Advantages of Frozen egg IVF technique
6.3.3. Disadvantages of frozen egg IVF technique
6.3.4. Global frozen egg IVF cycle market, by region
6.4. DONOR EGG IVF TECHNIQUE
6.4.1. Benefits of donor egg IVF technique
6.4.2. Risks associated with donor egg IVF cycle technique
6.4.3. Global donor egg IVF cycle market by region
CHAPTER 7 IVF DEVICES AND CONSUMABLES MARKET BY END USERS
7.1. GLOBAL IVF MARKET BY END USERS, 2014-2023 ($MILLION)
7.2. HOSPITALS
7.2.1. Global IVF hospitals end-user market by Region
7.3. SURGICAL CENTERS
7.3.1. Global IVF surgical centers end-user market by region
7.4. CLINICAL RESEARCH INSTITUTES
7.4.1. Global IVF clinical research institutes end-user market by region
7.5. CLINICS
7.5.1. Global IVF Clinics end-users market by region
CHAPTER 8 IVF DEVICES AND CONSUMABLES MARKET BY GEOGRAPHY
8.1. NORTH AMERICA
8.1.1. North America IVF Devices and Consumables Market, By components
8.1.2. U.S. IVF devices and consumables market
8.1.3. Canada IVF devices and consumables market
8.1.4. Mexico IVF devices and consumables market
8.2. EUROPE
8.2.1. Europe IVF Devices and Consumables Market, By Component
8.2.2. Germany IVF devices and consumables market
8.2.3. France IVF devices and consumables market
8.2.4. UK IVF devices and consumables market
8.2.5. Other Europe IVF devices and consumables market
8.3. ASIA-PACIFIC
8.3.1. Asia-Pacific IVF Devices and Consumables Market, By Component
8.3.2. India IVF devices and consumables market
8.3.3. China IVF devices and consumables market
8.3.4. Japan IVF devices and consumables market
8.3.5. Australia IVF devices and consumables market
8.3.6. Other Asia-Pacific IVF devices and consumables market
8.4. LAMEA
8.4.1. LAMEA IVF Devices and Consumables Market, By Component
8.4.2. Latin America IVF devices and consumables market
8.4.2.1. Brazil IVF devices and consumables market
8.4.3. Middle East IVF devices and consumables market
8.4.4. Africa IVF devices and consumables market
CHAPTER 9 COMPANY PROFILE
9.1. COOK MEDICAL, INC.
9.1.1. Company overview
9.1.2. SWOT analysis of Cook Medical, Inc.
9.2. COOPER COMPANIES, INC. (COOPER SURGICAL, INC.)
9.2.1. Company overview
9.2.2. Business performance
9.2.3. Strategic moves and developments
9.2.4. SWOT analysis of Cooper Surgical, Inc.
9.3. GENEA BIOMEDX
9.3.1. Company overview
9.3.2. Strategic moves and developments
9.3.3. SWOT analysis of Genea Biomedx
9.4. JXTG HOLDINGS, INC.
9.4.1. Company overview
9.4.2. Business performance
9.4.3. Strategic moves and developments
9.4.4. SWOT analysis of JX Holdings
9.5. MERCK KGAA (EMD SERONO, INC.)
9.5.1. Company overview
9.5.2. Business performance
9.5.3. Strategic moves and developments
9.5.4. SWOT analysis of Merck KGaA
9.6. OVASCIENCE INC.
9.6.1. Company overview
9.6.2. Business performance
9.6.3. Strategic moves and developments
9.6.4. SWOT analysis of OvaScience, Inc.
9.7. OXFORD GENE TECHNOLOGY
9.7.1. Company overview
9.7.2. Strategic moves and developments
9.7.3. SWOT analysis of Oxford Gene Technology
9.8. PROGYNY, INC.
9.8.1. Company overview
9.8.2. Strategic moves and developments
9.8.3. SWOT analysis of Progyny, Inc.
9.9. THERMO FISHER SCIENTIFIC INC.
9.9.1. Company overview
9.9.2. Business performance
9.9.3. Strategic moves and developments
9.9.4. SWOT analysis of Thermo Fisher Scientific, Inc.
9.10. VITROLIFE AB
9.10.1. Company overview
9.10.2. Business performance
9.10.3. Strategic moves and developments
9.10.4. SWOT analysis of Vitrolife AB
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENT
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. ALTERNATIVE TECHNOLOGIES
3.2.1. Intrauterine insemination (IUI) technique
3.2.1.1. Factors assessed for the procedure
3.2.1.2. Benefits of this technique
3.2.1.3. Risks
3.2.2. Difference between IUI and IVF technique
3.2.3. GIFT technique
3.2.3.1. Difference between GIFT and IVF technique
3.2.4. ZIFT technique
3.2.4.1. Differences between ZIFT and IVF technique
3.3. REPLACING IVF PROCEDURES BY FERTILITY DRUGS AND SURGERIES
3.3.1. Female infertility treatments
3.3.1.1. Limitations of fertility drugs
3.3.2. Male infertility treatments
3.4. COSTS RELATED TO IVF PROCEDURES
3.5. ROLE OF DONORS IN THE IVF MARKET
3.5.1. Egg donation
3.5.2. Egg sharing
3.5.3. Sperm donation
3.5.4. Embryo donation/adoption
3.5.5. Donation for research
3.6. SURROGACY
3.6.1. Legal issues
3.7. IVF TRENDS IN SAME SEX COUPLES
3.7.1. Artificial insemination
3.7.2. Surrogate mothers
3.7.3. In-vitro fertilization
3.8. ADVANCED IVF TECHNOLOGIES
3.8.1. Capsule IVF
3.8.2. Three parent IVF
3.8.2.1. Ethical concerns
3.8.3. Mini IVF
3.8.3.1. Advantages
3.8.3.2. Drawbacks
3.8.4. Embryo Scope
3.8.4.1. Advantages
3.8.5. PICSI
3.9. FERTILITY TREATMENT AND GENDER SELECTION
3.9.1. Methods of sex selection
3.9.1.1. Gradient method
3.9.1.2. Flow cytometry technique
3.9.1.3. Pre-implantation genetic diagnosis (PGD)
3.9.1.4. Ethical and legal issues
3.10. METABOLOMICS IN EMBRYO SCREENING METHODS
3.11. APPLICATION OF STEM CELLS IN IVF
3.12. IVF AND RESOURCE POOR COUNTRIES
3.13. KEY FINDINGS
3.13.1. Top impacting factors
3.13.2. Top investment pockets
3.13.3. Top winning strategies
3.14. PORTERS FIVE FORCES ANALYSIS
3.14.1. High competition and large number reduces the power of suppliers
3.14.2. Scattered nature and large count of end users moderates the buyer power
3.14.3. High capital cost lowers the threat of new entrants
3.14.4. Industry rivalry is intense due to presence of few dominant competitors
3.14.5. Lack of efficient substitutes lowers the threat from substitutes
3.15. VALUE CHAIN ANALYSIS
3.16. PATENT ANALYSIS
3.16.1. Patent analysis by year
3.16.2. Patents analysis by country
3.17. REGULATORY ISSUES AND LEGISLATIONS
3.18. INSURANCE REIMBURSEMENT SCENARIO
3.19. CLINICAL TRIALS
3.19.1. Trial 1: To study the DHEA outcomes on poor responders of IVF
3.19.2. Trial 2: Use of Metformin in IVF treatment of polycystic ovary syndrome
3.19.3. Trial 3- Treatment of first line unexplained infertility by IVF and IUI in controlled ovarian stimulation
3.19.4. Trial 4: Fast track to IVF (FASTT) Vs conventional infertility treatment
3.19.5. Trial 5: To study the evaluation of multiple doses of NT100 in women with repeated IVF failures
3.20. DRIVERS
3.20.1. Delayed pregnancies in women
3.20.2. Rise in global infertility rates
3.20.3. Advancement in technology
3.20.4. Rise in gamete donations
3.20.5. Rise in disposable income
3.20.6. Increase in success rates
3.21. RESTRAINTS
3.21.1. Cost constraints
3.21.2. Ethical and legal issues
3.21.3. Multiple pregnancies
3.21.4. Low awareness level
3.22. OPPORTUNITIES
3.22.1. Fertility tourism
3.22.2. Growing number of fertility clinics
3.22.3. Rise in same sex marriages
CHAPTER 4 IVF DEVICES MARKET, BY INSTRUMENTS
4.1. GLOBAL IVF MARKET BY INSTRUMENTS TYPES, 2014-2023, ($MILLION)
4.1.1. Incubators
4.1.1.1. Global IVF incubators market by region
4.1.2. Cryosystem
4.1.2.1. Global IVF cryosystem market by Region
4.1.3. Imaging system
4.1.3.1. Global IVF Imaging system market by Region
4.1.4. Cabinet (work station)
4.1.4.1. Global IVF cabinets market by Region
4.1.5. Ovum aspiration pump
4.1.5.1. Global IVF ovum aspiration pump market by Region
4.1.6. Sperm separation system
4.1.6.1. Global IVF sperm separation system market by Region
4.1.7. Micro Manipulator System
4.1.7.1. Global IVF Micromanipulator market by Region
4.1.8. Others
4.1.8.1. Global IVF other instruments market by Region
4.2. ACCESSORIES AND DISPOSABLES
4.2.1. Semen analysis chamber
4.2.2. Plastic ware
4.2.3. Oocyte retrieval needles
4.2.4. Miscellaneous disposables
4.2.5. Global IVF accessories and disposables market by region
CHAPTER 5 IVF DEVICES AND CONSUMABLES MARKET BY REAGENTS AND MEDIA
5.1. GLOBAL IVF MARKET BY REAGENTS AND MEDIA TYPES, 2014-2023, ($MILLION)
5.2. CRYOPRESERVATION MEDIA
5.2.1. Embryo cryopreservation media
5.2.2. Sperm cryopreservation media
5.2.3. Oocyte cryopreservation media
5.2.4. Global IVF cryopreservation media market by region
5.3. SEMEN PROCESSING MEDIA
5.3.1. Global IVF semen processing media market by region
5.4. OVUM PROCESSING MEDIA
5.4.1. Global IVF ovum processing media market by region
5.5. EMBRYO CULTURE MEDIA
5.5.1. Global IVF embryo culture media market by region
CHAPTER 6 IVF DEVICES AND CONSUMABLES MARKET BY TECHNIQUE
6.1. GLOBAL IVF MARKET, BY TECHNIQUE, 2014-2023 ($MILLION)
6.2. FRESH EMBRYO TRANSFER TECHNIQUE
6.2.1. Drivers
6.2.1.1. Trends of delayed pregnancies
6.2.1.2. Growing rates of infertility
6.2.2. Restraints
6.2.2.1. Cost involved in the treatment
6.2.2.2. Reimbursements issues with fresh embryo ivf cycles
6.2.3. Global fresh embryo IVF cycle market, by region
6.3. FROZEN EMBRYO TRANSFER TECHNIQUE (FER)
6.3.1. Reasons to use this technique
6.3.2. Advantages of Frozen egg IVF technique
6.3.3. Disadvantages of frozen egg IVF technique
6.3.4. Global frozen egg IVF cycle market, by region
6.4. DONOR EGG IVF TECHNIQUE
6.4.1. Benefits of donor egg IVF technique
6.4.2. Risks associated with donor egg IVF cycle technique
6.4.3. Global donor egg IVF cycle market by region
CHAPTER 7 IVF DEVICES AND CONSUMABLES MARKET BY END USERS
7.1. GLOBAL IVF MARKET BY END USERS, 2014-2023 ($MILLION)
7.2. HOSPITALS
7.2.1. Global IVF hospitals end-user market by Region
7.3. SURGICAL CENTERS
7.3.1. Global IVF surgical centers end-user market by region
7.4. CLINICAL RESEARCH INSTITUTES
7.4.1. Global IVF clinical research institutes end-user market by region
7.5. CLINICS
7.5.1. Global IVF Clinics end-users market by region
CHAPTER 8 IVF DEVICES AND CONSUMABLES MARKET BY GEOGRAPHY
8.1. NORTH AMERICA
8.1.1. North America IVF Devices and Consumables Market, By components
8.1.2. U.S. IVF devices and consumables market
8.1.3. Canada IVF devices and consumables market
8.1.4. Mexico IVF devices and consumables market
8.2. EUROPE
8.2.1. Europe IVF Devices and Consumables Market, By Component
8.2.2. Germany IVF devices and consumables market
8.2.3. France IVF devices and consumables market
8.2.4. UK IVF devices and consumables market
8.2.5. Other Europe IVF devices and consumables market
8.3. ASIA-PACIFIC
8.3.1. Asia-Pacific IVF Devices and Consumables Market, By Component
8.3.2. India IVF devices and consumables market
8.3.3. China IVF devices and consumables market
8.3.4. Japan IVF devices and consumables market
8.3.5. Australia IVF devices and consumables market
8.3.6. Other Asia-Pacific IVF devices and consumables market
8.4. LAMEA
8.4.1. LAMEA IVF Devices and Consumables Market, By Component
8.4.2. Latin America IVF devices and consumables market
8.4.2.1. Brazil IVF devices and consumables market
8.4.3. Middle East IVF devices and consumables market
8.4.4. Africa IVF devices and consumables market
CHAPTER 9 COMPANY PROFILE
9.1. COOK MEDICAL, INC.
9.1.1. Company overview
9.1.2. SWOT analysis of Cook Medical, Inc.
9.2. COOPER COMPANIES, INC. (COOPER SURGICAL, INC.)
9.2.1. Company overview
9.2.2. Business performance
9.2.3. Strategic moves and developments
9.2.4. SWOT analysis of Cooper Surgical, Inc.
9.3. GENEA BIOMEDX
9.3.1. Company overview
9.3.2. Strategic moves and developments
9.3.3. SWOT analysis of Genea Biomedx
9.4. JXTG HOLDINGS, INC.
9.4.1. Company overview
9.4.2. Business performance
9.4.3. Strategic moves and developments
9.4.4. SWOT analysis of JX Holdings
9.5. MERCK KGAA (EMD SERONO, INC.)
9.5.1. Company overview
9.5.2. Business performance
9.5.3. Strategic moves and developments
9.5.4. SWOT analysis of Merck KGaA
9.6. OVASCIENCE INC.
9.6.1. Company overview
9.6.2. Business performance
9.6.3. Strategic moves and developments
9.6.4. SWOT analysis of OvaScience, Inc.
9.7. OXFORD GENE TECHNOLOGY
9.7.1. Company overview
9.7.2. Strategic moves and developments
9.7.3. SWOT analysis of Oxford Gene Technology
9.8. PROGYNY, INC.
9.8.1. Company overview
9.8.2. Strategic moves and developments
9.8.3. SWOT analysis of Progyny, Inc.
9.9. THERMO FISHER SCIENTIFIC INC.
9.9.1. Company overview
9.9.2. Business performance
9.9.3. Strategic moves and developments
9.9.4. SWOT analysis of Thermo Fisher Scientific, Inc.
9.10. VITROLIFE AB
9.10.1. Company overview
9.10.2. Business performance
9.10.3. Strategic moves and developments
9.10.4. SWOT analysis of Vitrolife AB
LIST OF TABLES
TABLE 1. COMPARISON BETWEEN IUI AND IVF PROCEDURES
TABLE 2. COMPARISON BETWEEN GIFT AND IVF TECHNOLOGY
TABLE 3. COMPARISON BETWEEN ZIFT AND IVF TECHNOLOGY
TABLE 4. COST OF DONOR EGG PROCEDURE IN U.S. (2014)
TABLE 5. COST OF SPERM DONATION (2014)
TABLE 6. AVERAGE SURROGACY COSTS, 2014
TABLE 7. COMPARISON BETWEEN TRADITIONAL AND GESTATIONAL SURROGACY
TABLE 8. COMPARISON BETWEEN MINI IVF AND CONVENTIONAL IVF TECHNOLOGY
TABLE 9. APPLICATIONS OF PGD TECHNOLOGY
TABLE 10. PRODUCT LAUNCH AS A GROWTH STRATEGY BY THE KEY MARKET PLAYERS IN GLOBAL IVF DEVICES MARKET, 2014-2017
TABLE 11. AGREEMENT AS A GROWTH STRATEGY BY THE KEY MARKET PLAYERS IN GLOBAL IVF DEVICES MARKET, 2014-2017
TABLE 12. COLLABORATION AS A GROWTH STRATEGY BY THE KEY MARKET PLAYERS IN GLOBAL IVF DEVICES MARKET, 2014-2017
TABLE 13. INSURANCE COVERAGE FOR COUNTRIES
TABLE 14. INFERTILITY RATES IN NORTH AMERICA
TABLE 15. GLOBAL DISPOSABLE INCOME, 2014-2021
TABLE 16. IVF SUCCESS RATES BY AGE, EUROPE
TABLE 17. GLOBAL IVF DEVICES AND CONSUMABLES MARKET BY INSTRUMENTS TYPES, 2014-2023 ($MILLION)
TABLE 18. TECHNOLOGICAL VARIABLES FOR COMMERCIAL IVF INCUBATORS
TABLE 19. GLOBAL IVF INCUBATORS MARKET BY REGION, 2014-2023 ($MILLION)
TABLE 20. GLOBAL IVF CRYOSYSTEM MARKET BY REGION, 2014-2023 ($MILLION)
TABLE 21. GLOBAL IVF IMAGING SYSTEM MARKET BY REGION, 2014-2023 ($MILLION)
TABLE 22. GLOBAL IVF CABINETS MARKET BY REGION, 2014-2023 ($MILLION)
TABLE 23. GLOBAL IVF OVUM ASPIRATION PUMP MARKET BY REGION, 2014-2023 ($MILLION)
TABLE 24. MOTILITY OF SPERMS RETRIEVED THROUGH SPERM SEPARATION SYSTEM
TABLE 25. GLOBAL IVF SPERM SEPARATION SYSTEM MARKET BY REGION, 2014-2023 ($MILLION)
TABLE 26. GLOBAL IVF MICROMANIPULATOR MARKET BY REGION, 2014-2023 ($MILLION)
TABLE 27. GLOBAL IVF OTHER INSTRUMENTS MARKET BY REGION, 2014-2023 ($MILLION)
TABLE 28. GLOBAL IVF ACCESSORIES AND DISPOSABLE MARKET BY REGION, 2014-2023 ($MILLION)
TABLE 29. GLOBAL IVF DEVICES AND CONSUMABLES MARKET BY REAGENTS AND MEDIA TYPES, 2014-2023 ($MILLION)
TABLE 30. ADVANTAGES AND DISADVANTAGES OF CRYOPRESERVATION PROCEDURES
TABLE 31. CRYOPRESERVATION MEDIA BY VARIOUS COMPANIES
TABLE 32. GLOBAL IVF CRYOPRESERVATION MEDIA MARKET, BY REGION, 2014-2023 ($MILLION)
TABLE 33. COMMERCIALLY AVAILABLE SPERM PROCESSING MEDIA IN THE MARKET
TABLE 34. GLOBAL IVF SEMEN PROCESSING MEDIA MARKET BY REGION, 2014-2023 ($MILLION)
TABLE 35. GLOBAL IVF OVUM PROCESSING MEDIA MARKET BY REGION, 2014-2023 ($MILLION)
TABLE 36. EMBRYO CULTURE MEDIA BY VARIOUS COMPANIES
TABLE 37. GLOBAL IVF EMBRYO CULTURE MEDIA MARKET BY REGION, 2014-2023 ($MILLION)
TABLE 38. GLOBAL IVF DEVICES AND CONSUMABLES MARKET BY TECHNIQUE, 2014-2023 ($MILLION)
TABLE 39. GLOBAL FRESH EMBRYO IVF CYCLE MARKET BY REGION, 2014-2023 ($MILLION)
TABLE 40. COMPARISON BETWEEN FRESH AND FROZEN EMBRYO TRANSFER PROCEDURES
TABLE 41. GLOBAL FROZEN EGG IVF CYCLE MARKET BY REGION, 2014-2023 ($MILLION)
TABLE 42. GLOBAL DONOR EGG IVF CYCLE MARKET BY REGION, 2014-2023 ($MILLION)
TABLE 43. GLOBAL IVF DEVICES AND CONSUMABLES MARKET BY END USERS, 2014-2023 ($MILLION)
TABLE 44. GLOBAL IVF HOSPITALS END USER MARKET BY REGION, 2014-2023 ($MILLION)
TABLE 45. GLOBAL IVF SURGICAL CENTERS END USERS MARKET BY REGION, 2014-2023 ($MILLION)
TABLE 46. GLOBAL IVF CLINICAL RESEARCH INSTITUTES END USERS MARKET BY REGION, 2014-2023 ($MILLION)
TABLE 47. GLOBAL IVF CLINICS END USERS MARKET BY REGION, 2014-2023 ($MILLION)
TABLE 48. GLOBAL IVF DEVICES AND CONSUMABLES MARKET BY GEOGRAPHY, 2014-2023 ($MILLION)
TABLE 49. REGULATORY SCENARIO, NORTH AMERICA
TABLE 50. NORTH AMERICA IVF DEVICES AND CONSUMABLES MARKET, BY COMPONENTS, 2014-2023 ($MILLION)
TABLE 51. EUROPE IVF CYCLES IN 2014
TABLE 52. REGULATORY SCENARIO IN MANUFACTURING OF IVF DEVICES IN EUROPE
TABLE 53. REGULATORY SCENARIO, EUROPE
TABLE 54. EUROPE IVF DEVICES AND CONSUMABLES MARKET, BY COMPONENTS, 2014-2023 ($MILLION)
TABLE 55. POLICIES BY ASIAN COUNTRIES TO SUPPORT ART TREATMENT
TABLE 56. ASIA-PACIFIC IVF DEVICES AND CONSUMABLES MARKET, BY COMPONENTS, 2014-2023 ($MILLION)
TABLE 57. TYPE OF DATA COMPONENTS AND THEIR REQUIREMENTS
TABLE 58. REGULATORY SCENARIO, LAMEA
TABLE 59. LAMEA IVF DEVICES AND CONSUMABLES MARKET, BY COMPONENTS, 2014-2023 ($MILLION)
TABLE 60. BRAZIL IVF DEVICES AND CONSUMABLES MARKET, 2014-2023 ($MILLION)
TABLE 61. COOK MEDICAL, INC. BUSINESS SNAPSHOT
TABLE 62. COOPER COMPANIES, INC. BUSINESS SNAPSHOT
TABLE 63. GENEA BIOMEDX BUSINESS SNAPSHOT
TABLE 64. JX HOLDINGS BUSINESS SNAPSHOT
TABLE 65. MERCK KGAA BUSINESS SNAPSHOT
TABLE 66. OVASCIENCE, INC. BUSINESS SNAPSHOT
TABLE 67. OXFORD GENE TECHNOLOGY BUSINESS SNAPSHOT
TABLE 68. PROGYNY, INC. BUSINESS SNAPSHOT
TABLE 69. THERMO FISHER SCIENTIFIC INC. BUSINESS SNAPSHOT
TABLE 70. VITROLIFE AB BUSINESS SNAPSHOT
TABLE 1. COMPARISON BETWEEN IUI AND IVF PROCEDURES
TABLE 2. COMPARISON BETWEEN GIFT AND IVF TECHNOLOGY
TABLE 3. COMPARISON BETWEEN ZIFT AND IVF TECHNOLOGY
TABLE 4. COST OF DONOR EGG PROCEDURE IN U.S. (2014)
TABLE 5. COST OF SPERM DONATION (2014)
TABLE 6. AVERAGE SURROGACY COSTS, 2014
TABLE 7. COMPARISON BETWEEN TRADITIONAL AND GESTATIONAL SURROGACY
TABLE 8. COMPARISON BETWEEN MINI IVF AND CONVENTIONAL IVF TECHNOLOGY
TABLE 9. APPLICATIONS OF PGD TECHNOLOGY
TABLE 10. PRODUCT LAUNCH AS A GROWTH STRATEGY BY THE KEY MARKET PLAYERS IN GLOBAL IVF DEVICES MARKET, 2014-2017
TABLE 11. AGREEMENT AS A GROWTH STRATEGY BY THE KEY MARKET PLAYERS IN GLOBAL IVF DEVICES MARKET, 2014-2017
TABLE 12. COLLABORATION AS A GROWTH STRATEGY BY THE KEY MARKET PLAYERS IN GLOBAL IVF DEVICES MARKET, 2014-2017
TABLE 13. INSURANCE COVERAGE FOR COUNTRIES
TABLE 14. INFERTILITY RATES IN NORTH AMERICA
TABLE 15. GLOBAL DISPOSABLE INCOME, 2014-2021
TABLE 16. IVF SUCCESS RATES BY AGE, EUROPE
TABLE 17. GLOBAL IVF DEVICES AND CONSUMABLES MARKET BY INSTRUMENTS TYPES, 2014-2023 ($MILLION)
TABLE 18. TECHNOLOGICAL VARIABLES FOR COMMERCIAL IVF INCUBATORS
TABLE 19. GLOBAL IVF INCUBATORS MARKET BY REGION, 2014-2023 ($MILLION)
TABLE 20. GLOBAL IVF CRYOSYSTEM MARKET BY REGION, 2014-2023 ($MILLION)
TABLE 21. GLOBAL IVF IMAGING SYSTEM MARKET BY REGION, 2014-2023 ($MILLION)
TABLE 22. GLOBAL IVF CABINETS MARKET BY REGION, 2014-2023 ($MILLION)
TABLE 23. GLOBAL IVF OVUM ASPIRATION PUMP MARKET BY REGION, 2014-2023 ($MILLION)
TABLE 24. MOTILITY OF SPERMS RETRIEVED THROUGH SPERM SEPARATION SYSTEM
TABLE 25. GLOBAL IVF SPERM SEPARATION SYSTEM MARKET BY REGION, 2014-2023 ($MILLION)
TABLE 26. GLOBAL IVF MICROMANIPULATOR MARKET BY REGION, 2014-2023 ($MILLION)
TABLE 27. GLOBAL IVF OTHER INSTRUMENTS MARKET BY REGION, 2014-2023 ($MILLION)
TABLE 28. GLOBAL IVF ACCESSORIES AND DISPOSABLE MARKET BY REGION, 2014-2023 ($MILLION)
TABLE 29. GLOBAL IVF DEVICES AND CONSUMABLES MARKET BY REAGENTS AND MEDIA TYPES, 2014-2023 ($MILLION)
TABLE 30. ADVANTAGES AND DISADVANTAGES OF CRYOPRESERVATION PROCEDURES
TABLE 31. CRYOPRESERVATION MEDIA BY VARIOUS COMPANIES
TABLE 32. GLOBAL IVF CRYOPRESERVATION MEDIA MARKET, BY REGION, 2014-2023 ($MILLION)
TABLE 33. COMMERCIALLY AVAILABLE SPERM PROCESSING MEDIA IN THE MARKET
TABLE 34. GLOBAL IVF SEMEN PROCESSING MEDIA MARKET BY REGION, 2014-2023 ($MILLION)
TABLE 35. GLOBAL IVF OVUM PROCESSING MEDIA MARKET BY REGION, 2014-2023 ($MILLION)
TABLE 36. EMBRYO CULTURE MEDIA BY VARIOUS COMPANIES
TABLE 37. GLOBAL IVF EMBRYO CULTURE MEDIA MARKET BY REGION, 2014-2023 ($MILLION)
TABLE 38. GLOBAL IVF DEVICES AND CONSUMABLES MARKET BY TECHNIQUE, 2014-2023 ($MILLION)
TABLE 39. GLOBAL FRESH EMBRYO IVF CYCLE MARKET BY REGION, 2014-2023 ($MILLION)
TABLE 40. COMPARISON BETWEEN FRESH AND FROZEN EMBRYO TRANSFER PROCEDURES
TABLE 41. GLOBAL FROZEN EGG IVF CYCLE MARKET BY REGION, 2014-2023 ($MILLION)
TABLE 42. GLOBAL DONOR EGG IVF CYCLE MARKET BY REGION, 2014-2023 ($MILLION)
TABLE 43. GLOBAL IVF DEVICES AND CONSUMABLES MARKET BY END USERS, 2014-2023 ($MILLION)
TABLE 44. GLOBAL IVF HOSPITALS END USER MARKET BY REGION, 2014-2023 ($MILLION)
TABLE 45. GLOBAL IVF SURGICAL CENTERS END USERS MARKET BY REGION, 2014-2023 ($MILLION)
TABLE 46. GLOBAL IVF CLINICAL RESEARCH INSTITUTES END USERS MARKET BY REGION, 2014-2023 ($MILLION)
TABLE 47. GLOBAL IVF CLINICS END USERS MARKET BY REGION, 2014-2023 ($MILLION)
TABLE 48. GLOBAL IVF DEVICES AND CONSUMABLES MARKET BY GEOGRAPHY, 2014-2023 ($MILLION)
TABLE 49. REGULATORY SCENARIO, NORTH AMERICA
TABLE 50. NORTH AMERICA IVF DEVICES AND CONSUMABLES MARKET, BY COMPONENTS, 2014-2023 ($MILLION)
TABLE 51. EUROPE IVF CYCLES IN 2014
TABLE 52. REGULATORY SCENARIO IN MANUFACTURING OF IVF DEVICES IN EUROPE
TABLE 53. REGULATORY SCENARIO, EUROPE
TABLE 54. EUROPE IVF DEVICES AND CONSUMABLES MARKET, BY COMPONENTS, 2014-2023 ($MILLION)
TABLE 55. POLICIES BY ASIAN COUNTRIES TO SUPPORT ART TREATMENT
TABLE 56. ASIA-PACIFIC IVF DEVICES AND CONSUMABLES MARKET, BY COMPONENTS, 2014-2023 ($MILLION)
TABLE 57. TYPE OF DATA COMPONENTS AND THEIR REQUIREMENTS
TABLE 58. REGULATORY SCENARIO, LAMEA
TABLE 59. LAMEA IVF DEVICES AND CONSUMABLES MARKET, BY COMPONENTS, 2014-2023 ($MILLION)
TABLE 60. BRAZIL IVF DEVICES AND CONSUMABLES MARKET, 2014-2023 ($MILLION)
TABLE 61. COOK MEDICAL, INC. BUSINESS SNAPSHOT
TABLE 62. COOPER COMPANIES, INC. BUSINESS SNAPSHOT
TABLE 63. GENEA BIOMEDX BUSINESS SNAPSHOT
TABLE 64. JX HOLDINGS BUSINESS SNAPSHOT
TABLE 65. MERCK KGAA BUSINESS SNAPSHOT
TABLE 66. OVASCIENCE, INC. BUSINESS SNAPSHOT
TABLE 67. OXFORD GENE TECHNOLOGY BUSINESS SNAPSHOT
TABLE 68. PROGYNY, INC. BUSINESS SNAPSHOT
TABLE 69. THERMO FISHER SCIENTIFIC INC. BUSINESS SNAPSHOT
TABLE 70. VITROLIFE AB BUSINESS SNAPSHOT
LIST OF FIGURES
FIGURE 1. IVF DEVICES MARKET DEFINITION
FIGURE 2. ASIA-PACIFIC ADOPTION RATE BY TYPE OF SURROGACY
FIGURE 3. TOP IMPACTING FACTORS (2014-2020)
FIGURE 4. TOP INVESTMENT POCKETS OF GLOBAL IVF DEVICES MARKET (2014-2023)
FIGURE 5. TOP WINNING STRATEGIES: PERCENTAGE AND DISTRIBUTION
FIGURE 6. TOP WINNING STRATEGIES IN GLOBAL IVF DEVICES MARKET (NATURE AND COMPANY), 2014-2017
FIGURE 7. TOP WINNING STRATEGIES IN GLOBAL IVF DEVICES MARKE (NATURE AND TYPE), 2014-2017
FIGURE 8. PORTERS FIVE FORCES ANALYSIS
FIGURE 9. VALUE CHAIN ANALYSIS OF GLOBAL IVF MARKET
FIGURE 10. PATENT ANALYSIS BY YEAR (2011-2016)
FIGURE 11. PATENT ANALYSIS BY GEOGRAPHY (2011-2016)
FIGURE 12. EFFECT OF AGE ON FERTILITY
FIGURE 13. COMPARISON OF THE MEDIAS USED IN EMBRYO CULTURE
FIGURE 14. SUCCESS RATE OF IVF TECHNIQUES PERFORMED BY AGE, U.S.
FIGURE 15. PREGNANCY RATE, PER FROZEN EMBRYO TRANSFER, (U.S.)
FIGURE 16. SWOT ANALYSIS OF COOK MEDICAL, INC.
FIGURE 17. COOPER COMPANIES, INC. FINANCIAL REVENUE BY YEAR, 2014-2016 ($MILLION)
FIGURE 18. COOPER COMPANIES, INC. FINANCIAL REVENUE BY BUSINESS UNIT, 2016
FIGURE 19. COOPER COMPANIES, INC. FINANCIAL REVENUE BY GEOGRAPHY, 2016
FIGURE 20. SWOT ANALYSIS OF COOPER SURGICAL, INC.
FIGURE 21. SWOT ANALYSIS OF GENEA BIOMEDX
FIGURE 22. JX HOLDINGS FINANCIAL REVENUE BY YEAR, 2014-2016 ($MILLION)
FIGURE 23. JX HOLDINGS FINANCIAL REVENUE BY BUSINESS UNIT, 2016
FIGURE 24. JX HOLDINGS FINANCIAL REVENUE BY GEOGRAPHY, 2016
FIGURE 25. SWOT ANALYSIS OF JX HOLDINGS
FIGURE 26. MERCK KGAA FINANCIAL REVENUE BY YEAR, 2014-2016 ($MILLION)
FIGURE 27. MERCK KGAA FINANCIAL REVENUE BY BUSINESS UNIT, 2016
FIGURE 28. MERCK KGAA FINANCIAL REVENUE BY GEOGRAPHY, 2016
FIGURE 29. SWOT ANALYSIS OF MERCK KGAA
FIGURE 30. OVASCIENCE, INC. REVENUE, 2015-2016 ($MILLION)
FIGURE 31. SWOT ANALYSIS OF OVASCIENCE, INC.
FIGURE 32. SWOT ANALYSIS OF OXFORD GENE TECHNOLOGY
FIGURE 33. SWOT ANALYSIS OF PROGYNY, INC.
FIGURE 34. THERMO FISHER SCIENTIFIC, INC. FINANCIAL REVENUE BY YEAR, 2014-2016 ($MILLION)
FIGURE 35. THERMO FISHER SCIENTIFIC, INC. FINANCIAL REVENUE BY BUSINESS UNIT, 2016
FIGURE 36. THERMO FISHER SCIENTIFIC, INC. FINANCIAL REVENUE BY GEOGRAPHY, 2016
FIGURE 37. SWOT ANALYSIS OF THERMO FISHER SCIENTIFIC, INC.
FIGURE 38. VITROLIFE INC. FINANCIAL REVENUE BY YEAR, 2014-2016 ($MILLION)
FIGURE 39. VITROLIFE INC. FINANCIAL REVENUE BY BUSINESS UNIT, 2016
FIGURE 40. VITROLIFE INC., FINANCIAL REVENUE BY GEOGRAPHY, 2016
FIGURE 41. SWOT ANALYSIS OF VITROLIFE AB
FIGURE 1. IVF DEVICES MARKET DEFINITION
FIGURE 2. ASIA-PACIFIC ADOPTION RATE BY TYPE OF SURROGACY
FIGURE 3. TOP IMPACTING FACTORS (2014-2020)
FIGURE 4. TOP INVESTMENT POCKETS OF GLOBAL IVF DEVICES MARKET (2014-2023)
FIGURE 5. TOP WINNING STRATEGIES: PERCENTAGE AND DISTRIBUTION
FIGURE 6. TOP WINNING STRATEGIES IN GLOBAL IVF DEVICES MARKET (NATURE AND COMPANY), 2014-2017
FIGURE 7. TOP WINNING STRATEGIES IN GLOBAL IVF DEVICES MARKE (NATURE AND TYPE), 2014-2017
FIGURE 8. PORTERS FIVE FORCES ANALYSIS
FIGURE 9. VALUE CHAIN ANALYSIS OF GLOBAL IVF MARKET
FIGURE 10. PATENT ANALYSIS BY YEAR (2011-2016)
FIGURE 11. PATENT ANALYSIS BY GEOGRAPHY (2011-2016)
FIGURE 12. EFFECT OF AGE ON FERTILITY
FIGURE 13. COMPARISON OF THE MEDIAS USED IN EMBRYO CULTURE
FIGURE 14. SUCCESS RATE OF IVF TECHNIQUES PERFORMED BY AGE, U.S.
FIGURE 15. PREGNANCY RATE, PER FROZEN EMBRYO TRANSFER, (U.S.)
FIGURE 16. SWOT ANALYSIS OF COOK MEDICAL, INC.
FIGURE 17. COOPER COMPANIES, INC. FINANCIAL REVENUE BY YEAR, 2014-2016 ($MILLION)
FIGURE 18. COOPER COMPANIES, INC. FINANCIAL REVENUE BY BUSINESS UNIT, 2016
FIGURE 19. COOPER COMPANIES, INC. FINANCIAL REVENUE BY GEOGRAPHY, 2016
FIGURE 20. SWOT ANALYSIS OF COOPER SURGICAL, INC.
FIGURE 21. SWOT ANALYSIS OF GENEA BIOMEDX
FIGURE 22. JX HOLDINGS FINANCIAL REVENUE BY YEAR, 2014-2016 ($MILLION)
FIGURE 23. JX HOLDINGS FINANCIAL REVENUE BY BUSINESS UNIT, 2016
FIGURE 24. JX HOLDINGS FINANCIAL REVENUE BY GEOGRAPHY, 2016
FIGURE 25. SWOT ANALYSIS OF JX HOLDINGS
FIGURE 26. MERCK KGAA FINANCIAL REVENUE BY YEAR, 2014-2016 ($MILLION)
FIGURE 27. MERCK KGAA FINANCIAL REVENUE BY BUSINESS UNIT, 2016
FIGURE 28. MERCK KGAA FINANCIAL REVENUE BY GEOGRAPHY, 2016
FIGURE 29. SWOT ANALYSIS OF MERCK KGAA
FIGURE 30. OVASCIENCE, INC. REVENUE, 2015-2016 ($MILLION)
FIGURE 31. SWOT ANALYSIS OF OVASCIENCE, INC.
FIGURE 32. SWOT ANALYSIS OF OXFORD GENE TECHNOLOGY
FIGURE 33. SWOT ANALYSIS OF PROGYNY, INC.
FIGURE 34. THERMO FISHER SCIENTIFIC, INC. FINANCIAL REVENUE BY YEAR, 2014-2016 ($MILLION)
FIGURE 35. THERMO FISHER SCIENTIFIC, INC. FINANCIAL REVENUE BY BUSINESS UNIT, 2016
FIGURE 36. THERMO FISHER SCIENTIFIC, INC. FINANCIAL REVENUE BY GEOGRAPHY, 2016
FIGURE 37. SWOT ANALYSIS OF THERMO FISHER SCIENTIFIC, INC.
FIGURE 38. VITROLIFE INC. FINANCIAL REVENUE BY YEAR, 2014-2016 ($MILLION)
FIGURE 39. VITROLIFE INC. FINANCIAL REVENUE BY BUSINESS UNIT, 2016
FIGURE 40. VITROLIFE INC., FINANCIAL REVENUE BY GEOGRAPHY, 2016
FIGURE 41. SWOT ANALYSIS OF VITROLIFE AB
